Austrian BioTech startup Epitome Therapeutics announces €4 ...

Austrian BioTech startup Epitome Therapeutics

HIGH Tx General

Strategy Notes

Keyword match: +6 relevant, -0 negative signals.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: €4
Type: funding program
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-09 OPEN → INELIGIBLE · This is a news article reporting that Epitome Therapeutics raised €4 million in a private funding round — it is not an open grant, fellowship, or application programme. There is no application process; the funding went to Epitome Therapeutics itself as a company.